Stock Library / ELV

ELV Healthcare Latest YouTube: Q2 2026 Published 2026-07-16

Elevance Health Inc

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest on YouTube Latest on Spotify Latest on Podbean Apple Podcasts Amazon Music iHeartRadio YouTube Music Company Website Back to Library

Latest earnings video

ELV Stock: Elevance Beat AND Raised Guidance — So Why Did It Fall?

Published 2026-07-16

Open YouTube Open Spotify Open Podbean Apple Podcasts

Library coverage

Episodes tracked

3

Episodes linked

3

Latest video

Q2 2026

2026-07-16

Podcast available

Yes

Current price

$400.54

+4.26 (+1.07%)

Trailing / Forward P/E

17.73x

Forward: 13.53x

Market cap / Volume

—

Volume: —

Revenue / Earnings Growth

1.4%

Earnings: -13.1%

Margins

4.6% op

Gross: 26.0% · Net: 2.5%

Balance sheet

1.52x current

Debt / Equity: 69.0

52-week range / Beta

$274.84 - $436.24

Beta: 0.69

Analyst target

$449.10

Upside: 12.1%

Cash / shareholder return

4.96% FCF yield

Dividend yield: 1.73%

Company context

Industry: Healthcare Plans

Country: United States

Employees: —

Price to book: 1.94x

Return on equity: 11.1%

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Price chart

Market context for ELV

Competitive view

ELV vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

Elevance Health Inc latest YouTube video thumbnail

Elevance Health Inc

ELV

YouTube Spotify Podbean

Latest video

Q2 2026

Growth profile looks mature or currently muted, which can cap multiple expansion unless execution improves.

Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.

Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.

Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.

Intuitive Surgical latest YouTube video thumbnail

Intuitive Surgical

ISRG

YouTube Spotify Podbean Apple

Latest video

Q2 2026

Growth profile looks strong right now, with above-average top-line and/or earnings momentum.

Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.

Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.

Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.

Johnson & Johnson latest YouTube video thumbnail

Johnson & Johnson

JNJ

YouTube Podbean Apple

Latest video

Q2 2026

Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.

Profitability is serviceable, but it does not obviously dominate peers on margin or cash conversion alone.

Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.

Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.

Market Cap

More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.

ELV

$86.86B

Elevance Health Inc

ISRG

$135.72B

Intuitive Surgical

JNJ

$651.25B

Johnson & Johnson

Trailing P/E

Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.

ELV

17.7x

Elevance Health Inc

ISRG

43.5x

Intuitive Surgical

JNJ

31.4x

Johnson & Johnson

Forward P/E

Forward P/E is often a better read on what investors are paying for the next year of earnings power.

ELV

13.5x

Elevance Health Inc

ISRG

31.4x

Intuitive Surgical

JNJ

22.0x

Johnson & Johnson

Revenue Growth

Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.

ELV

1.4%

Elevance Health Inc

ISRG

18.5%

Intuitive Surgical

JNJ

6.6%

Johnson & Johnson

Earnings Growth

Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.

ELV

-13.1%

Elevance Health Inc

ISRG

26.5%

Intuitive Surgical

JNJ

-0.9%

Johnson & Johnson

Operating Margin

Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.

ELV

4.6%

Elevance Health Inc

ISRG

33.6%

Intuitive Surgical

JNJ

29.2%

Johnson & Johnson

Gross Margin

Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.

ELV

26.0%

Elevance Health Inc

ISRG

66.7%

Intuitive Surgical

JNJ

68.1%

Johnson & Johnson

Net Margin

Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.

ELV

2.5%

Elevance Health Inc

ISRG

28.4%

Intuitive Surgical

JNJ

21.5%

Johnson & Johnson

Return on Equity

ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.

ELV

11.1%

Elevance Health Inc

ISRG

17.4%

Intuitive Surgical

JNJ

25.7%

Johnson & Johnson

Free Cash Flow Yield

Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.

ELV

5.0%

Elevance Health Inc

ISRG

1.9%

Intuitive Surgical

JNJ

2.6%

Johnson & Johnson

Debt to Equity

Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.

ELV

68.95x

Elevance Health Inc

ISRG

—

Intuitive Surgical

JNJ

57.71x

Johnson & Johnson

Current Ratio

A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.

ELV

1.52x

Elevance Health Inc

ISRG

4.96x

Intuitive Surgical

JNJ

1.09x

Johnson & Johnson

Beta

Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.

ELV

0.69

Elevance Health Inc

ISRG

1.46

Intuitive Surgical

JNJ

0.23

Johnson & Johnson

Dividend Yield

Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.

ELV

1.7%

Elevance Health Inc

ISRG

—

Intuitive Surgical

JNJ

2.0%

Johnson & Johnson

Analyst Upside

Higher analyst upside suggests the Street still sees room between current price and consensus fair value.

ELV

12.1%

Elevance Health Inc

ISRG

26.2%

Intuitive Surgical

JNJ

0.8%

Johnson & Johnson

Related research

Non-quarter videos featuring ELV

Special-topic videos, explainers, and shorts connected to this ticker.

All Research Sections

Shorts and Clips 2026-07-16

It Beat AND Raised Guidance — So Why Did It Fall? #ELV #healthcare #stocks

A fast Charged Alpha clip pointing viewers into the latest earnings coverage.

YouTube

Episode timeline

Episode archive for ELV

Each row is one earnings episode with every verified platform link available.

Q2 2026

Episode live

2026-07-16

Published youtube podcast complete

ELV Stock: Elevance Beat AND Raised Guidance — So Why Did It Fall?

Quarterly earnings-analysis entry for Elevance Health Inc. Use the links on the right to open the video or podcast episode.

YouTube Spotify Podcast Apple Podcasts Amazon Show iHeart Show YouTube Music

Q1 2026

Episode live

2026-04-23

Published youtube complete

ELV Stock: EPS Misses Estimates — Q1 2026 Earnings Analysis

Quarterly earnings-analysis entry for Elevance Health Inc. Use the links on the right to open the video or podcast episode.

YouTube Spotify Show Podbean Show Apple Podcasts Amazon Show iHeart Show YouTube Music

Deep Dive

Episode live

2026-04-22

Published podcast complete

Charged Alpha | Elevance Health Inc (ELV) | S&P 500 Deep Dive — Ep. 0

Quarterly earnings-analysis entry for Elevance Health Inc. Use the links on the right to open the video or podcast episode.

Spotify Show Podcast Apple Podcasts Amazon Show iHeart Show YouTube Music